Taken together, these consistent results in both A549 and SHP-77 lung cancer cell lines demonstrate that inhibition of ERK, JNK, p38 MAPK, and NF-κB signaling pathways plays a pivotal role in TQ’s regulatory effects. Here, NFKB1 is linked to lung carcinoma.